- Supported exchanges /
- LSE /
- CEL.LSE
Celadon Pharmaceuticals PLC (CEL LSE) stock market data APIs
p36.4
0.9(2.5%)
as of September 16, 2024
Price chart is built with Anychart
Celadon Pharmaceuticals Plc engages in the research, cultivation, manufacturing, and sale of cannabis-based medicines. The company primarily focuses on growing indoor hydroponic cannabis for use in medicinal products. Its products used to treat chronic pain, as well as autism spectrum disorders. Celadon Pharmaceuticals Plc was founded in 2018 and is headquartered in London, the United Kingdom.
Celadon Pharmaceuticals PLC Financial Data Overview
| 35.5 | |
| 36.4 | |
| - | |
| 37 | |
| 35 | |
| 20-140 | |
| 24 171 K | |
| 66 221 K | |
| 75 000 | |
| -0.03 | |
| -0.255 |
Our easy-to-use no-coding solutions help you get the data effortlessly:
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
General: {
Code:
'CEL',
Type:
'Common Stock',
Name:
'Celadon Pharmaceuticals PLC',
Exchange:
'LSE',
CurrencyCode:
'GBX',
CurrencyName:
'Pence sterling',
CurrencySymbol:
'p',
CountryName:
'UK',
CountryISO:
'GB',
OpenFigi:
NULL,
ISIN:
'GB00BDQYGP38',
CIK:
NULL,
EmployerIdNumber:
NULL,
FiscalYearEnd:
'December',
IPODate:
NULL,
InternationalDomestic:
NULL,
Sector:
'Healthcare',
Industry:
'Drug Manufacturers - Specialty & Generic',
}
Celadon Pharmaceuticals PLC Fundamental Data is available in our Financial Data APIs
- Net Revenue 75 000
- EBITDA -5 845 000
- Earnings Per Share -0.12
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Celadon Pharmaceuticals PLC Earnings via APIs
- Latest Release 2022-09-29
- EPS/Forecast NaN
Get Celadon Pharmaceuticals PLC End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Do you have any questions?
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
